Abdominal injections are generally recommended during tirzepatide dose escalation because abdominal fat produces a slightly slower, more gradual absorption curve
Some users notice no blood pressure changes
Common digestive side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and bloating
Within controlled research environments, measurable outcomes such as altered GH pulse amplitude, downstream IGF-1 pathway modulation, and changes in cellular repair signaling have been documented without the disruptive hormonal cascades seen in less selective secretagogues
The 72-hour rule The FDA prescribing information states that if you want to change your injection day, you must ensure at least 3 days (72 hours) between doses